Overview

Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis

Status:
Completed

Trial end date:
2018-03-28

Target enrollment:

Participant gender:

Summary

An international, multi-centre, prospective, open-label, non-controlled, single-group, 4-week trial in adolescent subjects with plaque psoriasis.

Phase:

Phase 2

Details

Lead Sponsor:

LEO Pharma